Table 4. Lipid A composition with genetic pmrB and other gene mutations of colistin-resistant Acinetobacter baumannii.
Relative percentage of each lipid A component peak (%)* | Genetic mutation not detected (N = 21) | Genetic mutation detected (N = 15) | P | pmrB gene single mutation (N = 7) | pmrB gene two mutations (N = 2) | pmrB gene and other mutation (N = 6) | P |
---|---|---|---|---|---|---|---|
Hexa | 24.8 (18.9–37.4) | 11.3 (8.7–14.7) | < 0.001 | 15.8 (10.8–19.2) | 11.9 (10.3–13.5) | 8.7 (2.0–11.3) | 0.099 |
Hexa+1-PE | 25.2 (20.0–32.8) | 19.2 (17.0–22.4) | 0.026 | 19.2 (17.4–22.0) | 14.7 (10.6–18.9) | 20.8 (16.7–23.5) | 0.588 |
Hexa+2-PE | 0.0 (0.0–1.1) | 3.6 (1.1–5.6) | 0.002 | 5.0 (3.0–6.4) | 4.1 (0.7–7.4) | 0.7 (0.0–3.6) | 0.074 |
Hepta | 21 (100.0%) | 15 (100.0%) | - | 7 (100.0%) | 2 (100.0%) | 6 (100.0%) | 0.247 |
Hepta+1-PE | 107.1 (84.6–127.7) | 175.9 (138.1–196.4) | < 0.001 | 175.9 (140.8–179.9) | 131.6 (118.5–144.7) | 196.4 (136.8–219.5) | 0.381 |
Hepta+2-PE | 1.8 (0.6–4.1) | 31.6 (25.2–36.9) | < 0.001 | 31.4 (29.4–34.8) | 27.1 (22.0–32.2) | 33.9 (11.4–42.6) | 0.944 |
Octa | 5.6 (0.0–10.0) | 6.0 (3.2–7.5) | 0.686 | 6.0 (5.1–6.7) | 3.4 (1.6–5.1) | 7.5 (0.0–8.2) | 0.479 |
Octa+1-PE | 71.3 (44.6–85.4) | 42.8 (31.8–70.1) | 0.127 | 51.5 ± 29.4 | 19.9 ± 4.5 | 65.0 ± 27.4 | 0.458 |
Octa+2-PE | 5.8 (3.0–13.9) | 85.3 (44.0–129.3) | < 0.001 | 55.3 (44.0–105.3) | 34.7 (31.0–38.4) | 125.8 (90.1–181.2) | 0.029 |
Octa+2-PE+4C-H2O | 0.0 (0.0–0.0) | 23.9 (15.8–52.6) | < 0.001 | 21.1 (4.4–46.4) | 15.8 (15.3–16.2) | 45.5 (32.1–58.2) | 0.201 |
Data are presented as number (%), mean±SD for parametric variables or median [1st quartile–3rd quartile] for non-parametric variables. Bold values are statistically significant (P<0.05)
*Data represent the relative intensity (%) and their range compared with hepta-acylated lipid A, set as 100%.
Abbreviations: Hexa, hexa-acylated lipid A; Hepta, hepta-acylated lipid A; Octa, octa-acylated lipid A; PE, phosphoethanolamine; C, carbon.